Harry McCann
Non-Executive Chair / Telix Pharmaceuticals
Harry McCann
Follow
Get notifications in MyBN when activity occurs.
Lists and Charts
Roles
Year started and most recent title
Total Shareholder Return as at 02/12/24
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 86th | AVJennings | 148.01% | 6.57% |
| 87th | Yandal Resources | 147.18% | -1.45% |
| 88th | Telix Pharmaceuticals | 145.44% | 70.94% |
| 89th | Regis Healthcare | 144.9% | 21.15% |
| 90th | Artrya | 144.41% | 0% |
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Related Information
Access to our data for Harry McCann is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Harry McCann is linked to 6 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.
X
